Literature DB >> 2917666

Carcinoma of the uterine cervix stage I and IIA: results of surgical treatment: complications, recurrence and survival.

G G Kenter1, A C Ansink, A P Heintz, E J Aartsen, J F Delemarre, A A Hart.   

Abstract

Between 1967 and 1981, 213 patients with carcinoma of the uterine cervix Stage I and IIA underwent an abdominovaginal radical hysterectomy with transperitoneal lymphadenectomy. In 1987 the overall 5-year survival rate was 87.5% and the 10-year survival 85%. Recurrences were seen in 29 patients (13.7%). Lymph node metastases occurred in 39 patients (18%). Five-year survival decreased from 94% without positive nodes to 65% with positive nodes. The median blood loss was 2100 cc. Fistulas were seen in 6.7% of the patients. Long-term voiding problems were encountered in 40.8%. In 25% of the women intercourse was impeded postoperatively because of shortening of the vagina. The results obtained with this type of radical surgery in cervical cancer Stages I-IIA are good and do not differ from other methods reported in the literature. However this also means that this more difficult and time-consuming approach does not improve survival rates. For this reason there are no reasons to change from the Wertheim operation to this combined approach.

Entities:  

Mesh:

Year:  1989        PMID: 2917666

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  To what extent should we perform parametrectomy in FIGO stage IB cervical cancer?

Authors:  Ali Ayhan; Eralp Başer; Polat Dursun; Asuman Nihan Haberal
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-06-01

2.  Factors predicting parametrial invasion in patients with early-stage cervical carcinomas.

Authors:  Heng-Cheng Hsu; Yi-Jou Tai; Yu-Li Chen; Ying-Cheng Chiang; Chi-An Chen; Wen-Fang Cheng
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

3.  Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical cancer.

Authors:  K Baessler; S Windemut; V Chiantera; C Köhler; J Sehouli
Journal:  Clin Transl Oncol       Date:  2021-05-18       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.